Small interfering RNA technology can improve dendritic cell-based vaccine potency

被引：0
|
作者：
不详
机构：
来源：
EXPERT REVIEW OF VACCINES | 2011年 / 10卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：939 / 939
页数：1
相关论文
共 50 条
  • [41] Uric acid enhances the antitumor immunity of dendritic cell-based vaccine
    Wang, Yihan
    Ma, Xuelei
    Su, Chao
    Peng, Bin
    Du, Jing
    Jia, Hongyuan
    Luo, Min
    Fang, Chunju
    Wei, Yuquan
    SCIENTIFIC REPORTS, 2015, 5
  • [42] Uric acid enhances the antitumor immunity of dendritic cell-based vaccine
    Yihan Wang
    Xuelei Ma
    Chao Su
    Bin Peng
    Jing Du
    Hongyuan Jia
    Min Luo
    Chunju Fang
    Yuquan Wei
    Scientific Reports, 5
  • [43] Dendritic Cell-Based Vaccine for the Treatment of Malignant Glioma: A Systematic Review
    Wang, Xuan
    Zhao, Hong-Yang
    Zhang, Fang-Cheng
    Sun, Yun
    Xiong, Zhi-Yong
    Jiang, Xiao-Bing
    CANCER INVESTIGATION, 2014, 32 (09) : 451 - 457
  • [44] Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number
    Simon Hawlina
    Helena H. Chowdhury
    Tomaž Smrkolj
    Robert Zorec
    Biology Direct, 17
  • [45] Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number
    Hawlina, Simon
    Chowdhury, Helena H.
    Smrkolj, Tomaz
    Zorec, Robert
    BIOLOGY DIRECT, 2022, 17 (01)
  • [46] Fabrication of cell-based arrays using micropatterned alkanethiol monolayers for the parallel silencing of specific genes by small interfering RNA
    Fujimoto, Hiroyuki
    Yoshizako, Satoru
    Kato, Koichi
    Iwata, Hiroo
    BIOCONJUGATE CHEMISTRY, 2006, 17 (06) : 1404 - 1410
  • [47] New developments in dendritic cell-based vaccinations:: RNA translated into clinics
    Grünebach, F
    Müller, MR
    Brossart, P
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (06) : 517 - 525
  • [48] Neoantigen in esophageal squamous cell carcinoma for dendritic cell-based cancer vaccine development
    Mohammad Mahdi Forghanifard
    Mehran Gholamin
    Omeed Moaven
    Moein Farshchian
    Martha Ghahraman
    Amir Aledavood
    Mohammad Reza Abbaszadegan
    Medical Oncology, 2014, 31
  • [49] Potency analysis of peptide, lysate and apoptotic cells as sources of tumor antigen(s) in dendritic cell-based vaccine immunotherapy in vivo.
    Shimizu, K
    Kotera, Y
    Mulé, JJ
    FASEB JOURNAL, 2001, 15 (05): : A1207 - A1207
  • [50] Neoantigen in esophageal squamous cell carcinoma for dendritic cell-based cancer vaccine development
    Forghanifard, Mohammad Mahdi
    Gholamin, Mehran
    Moaven, Omeed
    Farshchian, Moein
    Ghahraman, Martha
    Aledavood, Amir
    Abbaszadegan, Mohammad Reza
    MEDICAL ONCOLOGY, 2014, 31 (10)
12345